{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:36:00Z","timestamp":1792582560361,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ekir.2021.09.018","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T08:25:40Z","timestamp":1634113540000},"page":"474-482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["APOL1 Renal Risk Variants and Sickle Cell Trait Associations With Reduced Kidney Function in a Large Congolese Population-Based Study"],"prefix":"10.1016","volume":"7","author":[{"given":"Mannix Imani","family":"Masimango","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Jadoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Binns-Roemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor A.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest Kiswaya","family":"Sumaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl A.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Limou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2021.09.018_bib1","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/j.ajkd.2016.05.030","article-title":"Risk of ESRD in the United States","volume":"68","author":"Albertus","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2021.09.018_bib2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/archinte.1995.00430110121013","article-title":"Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors","volume":"155","author":"Perneger","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ekir.2021.09.018_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000357595","article-title":"Effect of food insecurity on chronic kidney disease in lower-income Americans","volume":"39","author":"Crews","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2021.09.018_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1681\/ASN.2004030162","article-title":"Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study","volume":"16","author":"Young","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.09.018_bib5","first-page":"1","article-title":"Hypertension prevalence and control among adults: United States, 2015-2016","volume":"289","author":"Fryar","year":"2017","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ekir.2021.09.018_bib6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ekir.2021.09.018_bib7","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.09.018_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"key":"10.1016\/j.ekir.2021.09.018_bib9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2021.09.018_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature01461","article-title":"Apolipoprotein L-I is the trypanosome lytic factor of human serum","volume":"422","author":"Vanhamme","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ekir.2021.09.018_bib11","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-associated nephropathy in Black South Africans","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.09.018_bib12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.ackd.2014.06.005","article-title":"APOL1 kidney risk alleles: population genetics and disease associations","volume":"21","author":"Limou","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.ekir.2021.09.018_bib13","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ekir.2019.04.002","article-title":"APOL1 risk genotypes are associated with early kidney damage in children in sub-Saharan Africa","volume":"4","author":"Ekulu","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2021.09.018_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000353223","article-title":"High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria","volume":"123","author":"Ulasi","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.ekir.2021.09.018_bib15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/bmj.1.4857.290","article-title":"Protection afforded by sickle-cell trait against subtertian malareal infection","volume":"1","author":"Allison","year":"1954","journal-title":"Br Med J"},{"key":"10.1016\/j.ekir.2021.09.018_bib16","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/17474086.2017.1395279","article-title":"The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait","volume":"10","author":"Naik","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.ekir.2021.09.018_bib17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1681\/ASN.2009070705","article-title":"High prevalence of sickle cell trait in African Americans with ESRD","volume":"21","author":"Derebail","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.09.018_bib18","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1001\/jama.2014.15063","article-title":"Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans","volume":"312","author":"Naik","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2021.09.018_bib19","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2016101086","article-title":"Sickle cell trait and the risk of ESRD in Blacks","volume":"28","author":"Naik","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.09.018_bib20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1182\/blood.V48.5.629.629","article-title":"Abnormal hemoglobins in a quarter million people","volume":"48","author":"Schneider","year":"1976","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2021.09.018_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ncomms1104","article-title":"Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis","volume":"1","author":"Piel","year":"2010","journal-title":"Nat Commun"},{"key":"10.1016\/j.ekir.2021.09.018_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/njcp.njcp_253_18","article-title":"Study of association between sickle cell trait and renal dysfunction among young adults in South-West Nigeria","volume":"22","author":"Akinbodewa","year":"2019","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.ekir.2021.09.018_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5830\/CVJA-2014-076","article-title":"Sickle cell trait is not associated with chronic kidney disease in adult Congolese patients: a clinic-based, cross-sectional study","volume":"26","author":"Mukendi","year":"2015","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.ekir.2021.09.018_bib24","first-page":"733","article-title":"Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility","volume":"6","author":"Rebbeck","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ekir.2021.09.018_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/mutage\/geq014","article-title":"Genetic polymorphisms of glutathione S-transferase genes GSTM1, GSTT1 and risk of coronary heart disease","volume":"25","author":"Wang","year":"2010","journal-title":"Mutagenesis"},{"key":"10.1016\/j.ekir.2021.09.018_bib26","doi-asserted-by":"crossref","first-page":"F348","DOI":"10.1152\/ajprenal.00568.2012","article-title":"Loss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive kidney disease in the African American Study of Kidney Disease (AASK)","volume":"304","author":"Chang","year":"2013","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ekir.2021.09.018_bib27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000028396","article-title":"Glutathione S-transferase polymorphisms and their biological consequences","volume":"61","author":"Hayes","year":"2000","journal-title":"Pharmacology"},{"key":"10.1016\/j.ekir.2021.09.018_bib28","first-page":"1239","article-title":"Metabolic gene polymorphism frequencies in control populations","volume":"10","author":"Garte","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ekir.2021.09.018_bib29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.ekir.2020.05.028","article-title":"Prevalence and risk factors of CKD in South Kivu, Democratic Republic of Congo: a large-scale population study","volume":"5","author":"Masimango","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2021.09.018_bib30","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"suppl 1","key":"10.1016\/j.ekir.2021.09.018_bib31","first-page":"S62","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ekir.2021.09.018_bib32","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.kint.2019.01.016","article-title":"Improving glomerular filtration rate estimation","volume":"95","author":"Levey","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2021.09.018_bib33","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.kint.2018.11.045","article-title":"Performance of creatinine- or cystatin C-based equations to estimate glomerular filtration rate in sub-Saharan African populations","volume":"95","author":"Bukabau","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2021.09.018_bib34","first-page":"1","article-title":"KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2021.09.018_bib35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/ckj\/sfy073","article-title":"G1 is the major APOL1 risk allele for hypertension-attributed nephropathy in Central Africa","volume":"12","author":"Sumaili","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2021.09.018_bib36","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1093\/hmg\/ddab024","article-title":"Kidney disease and APOL1","volume":"30","author":"Yusuf","year":"2021","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ekir.2021.09.018_bib37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.kint.2021.03.038","article-title":"Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria","volume":"100","author":"Wudil","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2021.09.018_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181811","article-title":"APOL1 risk alleles among individuals with CKD in Northern Tanzania: a pilot study","volume":"12","author":"Stanifer","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2021.09.018_bib39","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/ndt\/gfr796","article-title":"APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease","volume":"27","author":"Tzur","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2021.09.018_bib40","first-page":"1785","article-title":"Serum soluble transferrin receptor concentrations are elevated in Congolese children with glucose-6-phosphate dehydrogenase variants, but not sickle cell variants or \u03b1-thalassemia","volume":"147","author":"Barker","year":"2017","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.ekir.2021.09.018_bib41","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejim.2004.06.003","article-title":"Sickle cell trait and gender influence type 2 diabetic complications in African patients","volume":"15","author":"Ajayi","year":"2004","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ekir.2021.09.018_bib42","first-page":"162","article-title":"Co-inheritance of autosomal dominant polycystic kidney disease and sickle cell trait in African Americans. Article in Spanish","volume":"31","author":"Peces","year":"2011","journal-title":"Nefrologia"},{"key":"10.1016\/j.ekir.2021.09.018_bib43","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2011.08832.x","article-title":"MYH9 and APOL1 are both associated with sickle cell disease nephropathy","volume":"155","author":"Ashley-Koch","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ekir.2021.09.018_bib44","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1681\/ASN.2015050487","article-title":"Combined effects of GSTM1 null allele and APOL1 renal risk alleles in CKD progression in the African American study of kidney disease and hypertension trial","volume":"27","author":"Bodonyi-Kovacs","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.09.018_bib45","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s11033-010-0221-0","article-title":"GSTT1 and GSTM1 gene polymorphisms in European and African populations","volume":"38","author":"Piacentini","year":"2011","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.ekir.2021.09.018_bib46","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1681\/ASN.2017030228","article-title":"The loss of GSTM1 associates with kidney failure and heart failure","volume":"28","author":"Tin","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.09.018_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jhh.2009.70","article-title":"Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options","volume":"24","author":"Kao","year":"2010","journal-title":"J\u00a0Hum Hypertens"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024921014595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024921014595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T02:12:02Z","timestamp":1699668722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024921014595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2468024921014595"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2021.09.018","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOL1 Renal Risk Variants and Sickle Cell Trait Associations With Reduced Kidney Function in a Large Congolese Population-Based Study","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2021.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2021.12.036","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}